Search results
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE...
PAHomePage.com· 4 hours agoVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog's ...
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 21 hours agoVertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years....
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lessened by Hussman Strategic...
ETF DAILY NEWS· 23 hours agoHussman Strategic Advisors Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 59.6% during the fourth quarter, according ...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
Zacks via Yahoo Finance· 4 days agoVertex (VRTX) begins rolling NDA submission for its investigational non-opioid candidate,...
Vertex Energy Inc (VTNR) Shares Rise Despite Market Challenges – News Heater
NewsHeater· 1 day agoVertex Energy Inc (NASDAQ: VTNR) has experienced a rise in its stock price by 13.74 compared to its previous closing price of 1.31. Business Wire reported 2024-04-10 that ...
Is Vertex (VRTX) a Buy as Wall Street Analysts Look Optimistic?
Zacks via Yahoo Finance· 7 days agoAccording to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is...
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) continues to grab headlines. Over the past six...
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Raised to $450.00
ETF DAILY NEWS· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price lifted by equities research analysts at Guggenheim from $445.00 to $450.00 in a research note issued ...
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Zacks via Yahoo Finance· 3 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $394.28, moving +0.2% from the...